المؤلفون: Broer LN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Knapen DG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Groot DA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Mol PGM; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kosterink JGW; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Pharmaco-, Therapy-, Epidemiology- and Economy, Groningen Research Institute for Pharmacy, University of Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

المصدر: IScience [iScience] 2024 May 24; Vol. 27 (6), pp. 110115. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

المؤلفون: Knapen DG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hone Lopez S; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Haan JJ; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Dienstmann R; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Universitat Autónoma de Barcelona, Barcelona, Spain., de Jong S; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Bhattacharya A; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. r.s.n.fehrmann@umcg.nl.

المصدر: Communications medicine [Commun Med (Lond)] 2024 May 03; Vol. 4 (1), pp. 79. Date of Electronic Publication: 2024 May 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE

المؤلفون: van Kuilenburg ABP; Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory Genetic Metabolic Diseases, Amsterdam, the Netherlands., Pleunis-van Empel MCH; Medisch Spectrum Twente, Department of Oncology, Enschede, the Netherlands., Brouwer RB; Department of Clinical Chemistry and Laboratory Medicine, Medisch Spectrum Twente, Medlon BV, Enschede, the Netherlands., Sijben AEJ; Department of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands., Knapen DG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Oude Munnink TH; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., van Zanden JJ; Martini Hospital Groningen, Certe Department of Clinical Chemistry, the Netherlands., Janssens-Puister J; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Dobritzsch D; Department of Chemistry, Uppsala University, Biomedical Center, Uppsala, Sweden., Meinsma R; Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory Genetic Metabolic Diseases, Amsterdam, the Netherlands., Meijer-Jansen J; Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory Genetic Metabolic Diseases, Amsterdam, the Netherlands., van Dooren SJM; Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory Genetic Metabolic Diseases, Amsterdam, the Netherlands., Vijzelaar R; MRC-Holland bv, Amsterdam, the Netherlands., Pop A; Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory Genetic Metabolic Diseases, Amsterdam, the Netherlands., Salomons GS; Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory Genetic Metabolic Diseases, Amsterdam, the Netherlands., Maring JG; Departments of Clinical Pharmacy and Medical Oncology, Isala, Zwolle, the Netherlands., Niezen-Koning KE; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

المصدر: JCO precision oncology [JCO Precis Oncol] 2024 May; Vol. 8, pp. e2300599.

نوع المنشور: Journal Article; Case Reports

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Dihydropyrimidine Dehydrogenase Deficiency*/genetics , Capecitabine*/adverse effects , Dihydrouracil Dehydrogenase (NADP)*/genetics , Antimetabolites, Antineoplastic*/adverse effects , Antimetabolites, Antineoplastic*/therapeutic use, Humans ; Male ; Female ; Fatal Outcome ; Middle Aged

المؤلفون: Vermeulen OCB; Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Brouwer E; Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Slart RHJA; Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Faculty of Science and Technology, Department of Biomedical Photonic Imaging, University of Twente, Enschede, The Netherlands., Sandovici M; Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Rutgers A; Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hilterman TJ; Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Hiddinga B; Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Oosting SF; Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Jalving M; Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Heij AH; Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Knapen DG; Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hospers GAP; Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van der Geest KSM; Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Feb 09. Date of Electronic Publication: 2024 Feb 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

المؤلفون: Woerdenbag HJ; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., Olinga P; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., Kok EA; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., Brugman DAP; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., van Ark UF; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., Ramcharan AS; Transvaal Apotheek, Kempstraat 113, 2572 GC Den Haag, The Netherlands., Lebbink PW; Transvaal Apotheek, Kempstraat 113, 2572 GC Den Haag, The Netherlands., Hoogwater FJH; Department of Surgery, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Knapen DG; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Nijkamp MW; Department of Surgery, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

المصدر: Cancers [Cancers (Basel)] 2023 Apr 01; Vol. 15 (7). Date of Electronic Publication: 2023 Apr 01.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Knapen DG; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., de Haan JJ; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: d.j.a.de.groot@umcg.nl.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 Mar; Vol. 183, pp. 103918. Date of Electronic Publication: 2023 Jan 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Colonic Neoplasms*/genetics , Rectal Neoplasms*, Humans ; Chemotherapy, Adjuvant ; Microsatellite Instability

المؤلفون: Broer LN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Knapen DG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Suurs FV; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Moen I; Bayer AS, Oslo, Norway., Giesen D; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Waaijer SJH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Indrevoll B; Bayer AS, Oslo, Norway., Ellingsen C; Bayer AS, Oslo, Norway., Kristian A; Bayer AS, Oslo, Norway., Cuthbertson AS; Bayer AS, Oslo, Norway., de Groot DA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Cole PE; Bayer U.S., LLC, Whippany, New Jersey., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hagemann UB; Bayer AG, Berlin, Germany., Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and m.n.de.hooge@umcg.nl.; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Nov; Vol. 63 (11), pp. 1715-1721. Date of Electronic Publication: 2022 Apr 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms* , Immunoconjugates*, Animals ; Humans ; Mice ; Female ; Mesothelin ; Mice, Nude ; Tissue Distribution ; Apoptosis ; Cell Line, Tumor ; Zirconium/therapeutic use ; Positron-Emission Tomography/methods ; Chelating Agents

المؤلفون: van de Donk PP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Knapen DG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van der Wekken AJ; Department of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lub-de Hooge MN; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Groot DA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Vries EG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands e.g.e.de.vries@umcg.nl.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Aug; Vol. 10 (8).

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy*/methods , Neoplasms*/drug therapy , Neoplasms*/therapy, Antibodies, Monoclonal/therapeutic use ; Humans ; Molecular Imaging ; Positron-Emission Tomography/methods

المؤلفون: Knapen DG; Medical Oncology, University Medical Centre Groningen, Groningen, Groningen, Netherlands., Cherny NI; Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Jerusalem, Israel., Zygoura P; Statistics, Frontier Science Foundation-Hellas, Statistics, Athens, Zografou, Greece., Latino NJ; ESMO-MCBS Working Group, European Society for Medical Oncology, Viganello, Switzerland., Douillard JY; ESMO-MCBS Working Group, European Society for Medical Oncology, Viganello, Switzerland., Dafni U; Nursing, National and Kapodistrian University of Athens, Goudi-Athens, Greece; University of Athens, Athens, Greece., de Vries EGE; Medical Oncology, University Medical Centre Groningen, Groningen, Groningen, Netherlands., de Groot DJ; Medical Oncology, University Medical Centre Groningen, Groningen, Groningen, Netherlands. Electronic address: d.j.a.de.groot@umcg.nl.

المصدر: ESMO open [ESMO Open] 2020 Sep; Vol. 5 (5), pp. e000681.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Colonic Neoplasms*/drug therapy , Medical Oncology*, Fluorouracil/therapeutic use ; Humans ; Oxaliplatin ; United States ; United States Food and Drug Administration

المؤلفون: Knapen DG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kwee TC; Department of Radiology, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Meijne EIM; Department of Patient Care, Quality and Safety, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: e.g.e.de.vries@umcg.nl.

المصدر: Cancer treatment reviews [Cancer Treat Rev] 2020 Jul; Vol. 87, pp. 102027. Date of Electronic Publication: 2020 May 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Survivors/*statistics & numerical data , Neoplasms/*diagnostic imaging , Neoplasms, Radiation-Induced/*epidemiology, Adult ; Female ; Humans ; Magnetic Resonance Imaging/statistics & numerical data ; Male ; Neoplasms/drug therapy ; Neoplasms/epidemiology ; Neoplasms/immunology ; Neoplasms, Radiation-Induced/etiology ; Tomography, X-Ray Computed/statistics & numerical data ; Young Adult